Company news
Evopoint Biosciences Co Ltd news
Latest news releases, newest first.
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Report for Q3 2026
October 28, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors
October 28, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Resignation of Non-independent Director, Election of Employee Representative Director, and By-election of Member of the Audit Committee of the Board of Directors
October 28, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Change of Securities Affairs Representative
October 28, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Opening of Dedicated Settlement Accounts for Cash Management Products Purchased with Raised Funds
October 20, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Approval by the National Medical Products Administration of the Clinical Trial Application for XNW26018 Tablets
October 20, 2026
(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Opening of Dedicated Settlement Accounts for Cash Management Products Purchased with Raised Funds
October 15, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
October 9, 2026
Announcement on Opening of Dedicated Settlement Accounts for Cash Management Products Purchased with Raised Funds
October 7, 2026
Announcement on Resolutions of the 17th Meeting of the 2nd Board of Directors
September 23, 2026